HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Toru Kita Selected Research

Toru Kita Research Topics

Disease

37Atherosclerosis
11/2018 - 05/2002
24Myocardial Infarction
09/2017 - 01/2003
22Coronary Artery Disease (Coronary Atherosclerosis)
06/2022 - 01/2003
21Heart Failure
01/2013 - 11/2003
18Glomerulonephritis
01/2016 - 09/2003
16Hypercholesterolemia
04/2012 - 12/2002
15Hypertension (High Blood Pressure)
02/2021 - 01/2003
15Stroke (Strokes)
10/2015 - 11/2005
12Thrombosis (Thrombus)
06/2015 - 07/2003
12Hypertrophy
03/2010 - 05/2003
11Atherosclerotic Plaque (Atheroma)
12/2012 - 02/2004
10Acute Coronary Syndrome
09/2017 - 12/2004
10Hemorrhage
08/2014 - 02/2005
9Cardiovascular Diseases (Cardiovascular Disease)
10/2015 - 02/2004
8Coronary Disease (Coronary Heart Disease)
02/2021 - 12/2002
8Diabetic Nephropathies (Diabetic Nephropathy)
08/2015 - 04/2004
8Body Weight (Weight, Body)
03/2010 - 01/2003
7Inflammation (Inflammations)
03/2017 - 04/2007
6Type 2 Diabetes Mellitus (MODY)
10/2016 - 03/2002
6Diabetes Mellitus
01/2015 - 01/2004
6Obesity
03/2010 - 01/2003
6Metabolic Syndrome (Dysmetabolic Syndrome X)
03/2010 - 01/2003
5Neoplasms (Cancer)
01/2021 - 03/2004
5Alzheimer Disease (Alzheimer's Disease)
01/2014 - 06/2003
5Insulin Resistance
03/2010 - 03/2008
4Unstable Angina
09/2017 - 03/2007
4Myocardial Ischemia (Ischemic Heart Diseases)
09/2017 - 01/2003
4Cardiac Sudden Death (Sudden Cardiac Arrest)
02/2012 - 03/2007
4Rupture
09/2010 - 02/2004
4Hyperlipidemias (Hyperlipidemia)
01/2009 - 03/2002
4IGA Glomerulonephritis (IGA Nephropathy)
03/2007 - 08/2004
4Proteinuria
02/2007 - 03/2002
3Dyslipidemias (Dyslipidemia)
02/2021 - 06/2008
3Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
02/2021 - 01/2004
3Chronic Kidney Failure (Chronic Renal Failure)
01/2015 - 01/2006
3Chronic Renal Insufficiency
01/2015 - 08/2009
3Anemia
10/2011 - 06/2006
3Vascular Diseases (Vascular Disease)
01/2009 - 01/2004
3Vascular System Injuries
02/2008 - 03/2004
3Sarcoidosis (Schaumann Disease)
03/2007 - 07/2005
3Infections
03/2007 - 08/2003
3Reperfusion Injury
01/2007 - 01/2003

Drug/Important Bio-Agent (IBA)

29LipidsIBA
02/2021 - 05/2002
21oxidized low density lipoproteinIBA
02/2021 - 03/2002
18CholesterolIBA
06/2014 - 03/2002
14Proteins (Proteins, Gene)FDA Link
01/2021 - 05/2003
11Biomarkers (Surrogate Marker)IBA
09/2017 - 11/2006
10Glucose (Dextrose)FDA LinkGeneric
01/2021 - 08/2006
9Apolipoproteins E (ApoE)IBA
12/2012 - 09/2004
9ApolipoproteinsIBA
09/2011 - 12/2005
9Triglycerides (Triacylglycerol)IBA
03/2010 - 01/2003
9Simvastatin (Zocor)FDA LinkGeneric
03/2010 - 12/2002
8HDL CholesterolIBA
02/2021 - 01/2003
8Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
06/2016 - 07/2008
7LectinsIBA
09/2010 - 08/2005
7Class E Scavenger Receptors (Lectin Like Oxidized Low Density Lipoprotein Receptor 1)IBA
09/2010 - 07/2005
6LDL CholesterolIBA
02/2021 - 01/2004
6Eicosapentaenoic AcidIBA
01/2012 - 07/2008
5MicroRNAs (MicroRNA)IBA
03/2017 - 08/2009
5omega-Chloroacetophenone (Mace)IBA
10/2015 - 08/2009
5Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2015 - 02/2009
5Sirolimus (Rapamycin)FDA Link
04/2014 - 06/2005
5CytokinesIBA
11/2012 - 12/2002
5CollagenIBA
03/2010 - 05/2004
4Probucol (Lorelco)FDA Link
06/2022 - 12/2008
4LDL Lipoproteins (beta Lipoproteins)IBA
02/2021 - 01/2004
4Fatty Acids (Saturated Fatty Acids)IBA
01/2015 - 05/2010
4Peptides (Polypeptides)IBA
01/2014 - 12/2005
4C-Reactive ProteinIBA
09/2010 - 01/2006
4SaltsIBA
05/2010 - 11/2003
4Transcription Factors (Transcription Factor)IBA
03/2010 - 05/2003
4Chemokine CXCL16IBA
10/2009 - 02/2004
4Brain Natriuretic Peptide (Natrecor)FDA Link
02/2009 - 12/2004
4LDL Receptors (LDL Receptor)IBA
10/2008 - 01/2004
4Lipoproteins (Lipoprotein)IBA
06/2008 - 03/2002
4Troponin T (Troponin T1)IBA
05/2007 - 12/2004
4FibrinIBA
03/2007 - 07/2002
4Immunoglobulin A (IgA)IBA
03/2007 - 09/2003
3AntioxidantsIBA
02/2021 - 06/2007
3nardilysinIBA
01/2021 - 01/2014
3AntigensIBA
09/2017 - 12/2002
3MetalsIBA
04/2014 - 09/2008
3Amyloid beta-PeptidesIBA
01/2014 - 12/2005
3thienopyridineIBA
06/2012 - 02/2009
3Monoclonal AntibodiesIBA
03/2011 - 01/2003
3propagermanium (Ge 132)IBA
03/2010 - 09/2007
3Histone Acetyltransferases (Histone Acetyltransferase)IBA
03/2010 - 02/2006
3Phenylephrine (Neo-Synephrine)FDA LinkGeneric
03/2010 - 09/2004
3Superoxide DismutaseIBA
05/2009 - 09/2004
3Immunoglobulin G (IgG)IBA
10/2008 - 01/2003
3Cell Surface ReceptorsIBA
10/2008 - 07/2007
3DNA (Deoxyribonucleic Acid)IBA
04/2008 - 02/2006
3Transforming Growth Factor beta (TGF-beta)IBA
06/2007 - 02/2006
3Scavenger Receptors (Scavenger Receptor)IBA
04/2007 - 07/2002

Therapy/Procedure

27Therapeutics
02/2021 - 12/2002
18Percutaneous Coronary Intervention
06/2015 - 06/2005
16Stents
01/2015 - 12/2004
10Coronary Artery Bypass (Coronary Artery Bypass Surgery)
01/2013 - 03/2007
6Secondary Prevention
02/2021 - 12/2002
3Operative Surgical Procedures
08/2014 - 04/2012